Page last updated: 2024-08-21

adamantane and endomorphin 2

adamantane has been researched along with endomorphin 2 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Kastin, AJ; Zadina, JE1
Barna, I; Király, K; Kozsurek, M; Lambeir, AM; Luyten, W; Puskár, Z; Rónai, AZ; Szalai, J; Szentirmay, A1
Chang, XM; Fang, Q; Han, ZL; Li, N; Li, XH; Pan, JX; Tang, HH; Wang, P; Wang, R; Wang, ZL; Zheng, T1

Other Studies

3 other study(ies) available for adamantane and endomorphin 2

ArticleYear
Vasodilator responses to the endomorphin peptides, but not nociceptin/OFQ, are mediated by nitric oxide release.
    Annals of the New York Academy of Sciences, 1999, Volume: 897

    Topics: Adamantane; Analgesics, Opioid; Animals; Diuretics; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Hindlimb; Meclofenamic Acid; Morpholines; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nociceptin; Oligopeptides; Opioid Peptides; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents

1999
The dipeptidyl peptidase IV (CD26, EC 3.4.14.5) inhibitor vildagliptin is a potent antihyperalgesic in rats by promoting endomorphin-2 generation in the spinal cord.
    European journal of pharmacology, 2011, Jan-10, Volume: 650, Issue:1

    Topics: Adamantane; Animals; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Spinal; Injections, Subcutaneous; Male; Nitriles; Oligopeptides; Pyrrolidines; Rats; Rats, Wistar; Reproducibility of Results; Spinal Cord; Time Factors; Vildagliptin

2011
Opposite effects of neuropeptide FF on central antinociception induced by endomorphin-1 and endomorphin-2 in mice.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Adamantane; Animals; Benzeneacetamides; Dipeptides; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Injections, Intraventricular; Male; Mice; Naltrexone; Nociception; Oligopeptides; Pyrrolidines

2014